First AI-generated drug enters human clinical trials

[Kamaji]

First AI-generated drug enters human clinical trials, targeting chronic lung disease patients

By Melissa Rudy, Fox News
June 29, 2023

The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday.

The drug, currently referred to as INS018_055, is being tested to treat idiopathic pulmonary fibrosis (IPF), a rare, progressive type of chronic lung disease.

The 12-week trial will include participants diagnosed with IPF.

“This drug, which will be given orally, will undergo the same rigorous testing to ensure its effectiveness and safety, like traditionally discovered drugs, but the process of its discovery and design are incredibly new,” said Insilico Medicine’s CEO Alex Zhavoronkov, PhD, in a statement to Fox News Digital.

“However, with the latest advances in artificial intelligence, it was developed much faster than traditional drugs.”

*  *  *

Source:  https://nypost.com/2023/06/29/first-ai-generated-drug-enters-human-clinical-trials-targeting-chronic-lung-disease-patients/